Published in Medical Letter on the CDC and FDA, May 10th, 2006
"Carticel is an autologous cultured chondrocyte product that has been approved by the U.S. Food and Drug Administration (FDA) for the repair of symptomatic cartilaginous defects of the femoral condyle that are caused by acute or repetitive trauma in patients who have been previously managed with arthroscopy or other surgical procedures," note scientists in the United States. "The present report describes the adverse events following Carticel implantation as...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA